Home » Benign Prostatic Hyperplasia Devices Market
Benign Prostatic Hyperplasia Devices Market
Published date: Apr 2022 •Formats:
Request Sample Schedule a Call

Global Benign Prostatic Hyperplasia Devices Market By Type (Transurethral Resection of the Prostate (TURP), Transurethral Microwave Therapy (TUMT), Transurethral Needle Ablation of the Prostate (TUNA), Laser Surgery, Prostatic Stenting, Others), By Application (Hospitals and Clinics, Ambulatory Surgical Centers(ASC), Home, Others), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2019–2028

  • Published date: Apr 2022
  • Report ID: 25058
  • Number of Pages: 290
  • Format:
  • keyboard_arrow_up
    • 1. Global Benign Prostatic Hyperplasia Devices Market Introduction
      • 1.1. Definition
      • 1.2. Taxonomy
      • 1.3. Research Scope
    • 2. Executive Summary
      • 2.1. Key Findings by Major Segments
      • 2.2. Top strategies by Major Players
    • 3. Global Benign Prostatic Hyperplasia Devices Market Overview
      • 3.1. Global Benign Prostatic Hyperplasia Devices Market Dynamics
        • 3.1.1. Drivers
        • 3.1.2. Opportunities
        • 3.1.3. Restraints
        • 3.1.4. Challenges
      • 3.2. PESTLE Analysis
      • 3.3. Opportunity Map Analysis
      • 3.4. PORTER'S Five Forces Analysis
      • 3.5. Market Competition Scenario Analysis
      • 3.6. Product Life Cycle Analysis
      • 3.7. Opportunity Orbits
      • 3.8. Manufacturer Intensity Map
    • 4. Global Benign Prostatic Hyperplasia Devices Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
      • 4.1. Global Benign Prostatic Hyperplasia Devices Market Analysis by Type: Introduction
      • 4.2. Market Size and Forecast by Region
      • 4.3. Transurethral Resection of the Prostate (TURP)
      • 4.4. Transurethral Microwave Therapy (TUMT)
      • 4.5. Transurethral Needle Ablation of the Prostate (TUNA)
      • 4.6. Laser Surgery
      • 4.7. Prostatic Stenting
      • 4.8. Others
    • 5. Global Benign Prostatic Hyperplasia Devices Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
      • 5.1. Global Benign Prostatic Hyperplasia Devices Market Analysis by Application: Introduction
      • 5.2. Market Size and Forecast by Region
      • 5.3. Hospitals and Clinics
      • 5.4. Ambulatory Surgical Centers(ASC)
      • 5.5. Home
      • 5.6. Others
    • 6. Global Benign Prostatic Hyperplasia Devices Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
      • 6.1. North America
        • 6.1.1. North America Global Benign Prostatic Hyperplasia Devices Market: Regional Trend Analysis
          • 6.1.1. 1.US
          • 6.1.1. 2.Canada
          • 6.1.1. 3.Mexico
      • 6.2. Europe
        • 6.2.1. Europe Global Benign Prostatic Hyperplasia Devices Market: Regional Trend Analysis
          • 6.2.1.1. Germany
          • 6.2.1.2. France
          • 6.2.1.3. UK
          • 6.2.1.4. Russia
          • 6.2.1.5. Italy
          • 6.2.1.6. Rest of Europe
      • 6.3. Asia-Pacific
        • 6.3.1. Asia-Pacific Global Benign Prostatic Hyperplasia Devices Market: Regional Trend Analysis
          • 6.3.1.1. China
          • 6.3.1.2. Japan
          • 6.3.1.3. Korea
          • 6.3.1.4.India
          • 6.3.1.5.Rest of Asia
      • 6.4. Latin America
        • 6.4.1. Latin America Global Benign Prostatic Hyperplasia Devices Market: Regional Trend Analysis
          • 6.4.1.1. Brazil
          • 6.4.1.2. Argentina
          • 6.4.1.3. Rest of Latin America
      • 6.5. Middle East and Africa
        • 6.5.1. Middle East and Africa Global Benign Prostatic Hyperplasia Devices Market: Regional Trend Analysis
          • 6.5.1.1. GCC
          • 6.5.1.2. South Africa
          • 6.5.1.3. Israel
          • 6.5.1.4. Rest of MEA
    • 7. Global Benign Prostatic Hyperplasia Devices Market Competitive Landscape, Market Share Analysis, and Company Profiles
      • 7.1. Market Share Analysis
      • 7.2. Company Profiles
      • 7.3. Lumenis
        • 7.3.1. Company Overview
        • 7.3.2. Financial Highlights
        • 7.3.3. Product Portfolio
        • 7.3.4. SWOT Analysis
        • 7.3.5. Key Strategies and Developments
      • 7.4. Olympus corporation
        • 7.4.1. Company Overview
        • 7.4.2. Financial Highlights
        • 7.4.3. Product Portfolio
        • 7.4.4. SWOT Analysis
        • 7.4.5. Key Strategies and Developments
      • 7.5. Urologix
        • 7.5.1. Company Overview
        • 7.5.2. Financial Highlights
        • 7.5.3. Product Portfolio
        • 7.5.4. SWOT Analysis
        • 7.5.5. Key Strategies and Developments
      • 7.6. Boston Scientific corporation
        • 7.6.1. Company Overview
        • 7.6.2. Financial Highlights
        • 7.6.3. Product Portfolio
        • 7.6.4. SWOT Analysis
        • 7.6.5. Key Strategies and Developments
      • 7.7. Lisa Laser
        • 7.7.1. Company Overview
        • 7.7.2. Financial Highlights
        • 7.7.3. Product Portfolio
        • 7.7.4. SWOT Analysis
        • 7.7.5. Key Strategies and Developments
      • 7.8. Medifocus
        • 7.8.1. Company Overview
        • 7.8.2. Financial Highlights
        • 7.8.3. Product Portfolio
        • 7.8.4. SWOT Analysis
        • 7.8.5. Key Strategies and Developments
      • 7.9. Neotrac
        • 7.9.1. Company Overview
        • 7.9.2. Financial Highlights
        • 7.9.3. Product Portfolio
        • 7.9.4. SWOT Analysis
        • 7.9.5. Key Strategies and Developments
      • 7.10. ProArc Medical LTD
        • 7.10.1. Company Overview
        • 7.10.2. Financial Highlights
        • 7.10.3. Product Portfolio
        • 7.10.4. SWOT Analysis
        • 7.10.5. Key Strategies and Developments
      • 7.11. Urotech GMBH
        • 7.11.1. Company Overview
        • 7.11.2. Financial Highlights
        • 7.11.3. Product Portfolio
        • 7.11.4. SWOT Analysis
        • 7.11.5. Key Strategies and Developments
    • 8. Assumptions and Acronyms
    • 9. Research Methodology
    • 10. Contact
  • settingsSettings

Related Reports

Our Clients

  • Our Clients
Inquiry Before Buying

Benign Prostatic Hyperplasia Devices Market
  • 25058
  • Apr 2022
    • ★★★★★
      ★★★★★
    • (35)
  • US $5,999
    US $2,999
  • US $7,999
    US $3,499
  • US $12,999
    US $4,499
Buy Now
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$5,999
$2,999
USD / per unit
save 50%
 Multi User
$7,999
$3,499
USD / per unit
save 55%
 Corporate User
$12,999
$4,499
USD / per unit
save 65%
e-Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 2,999)Buy Now ($ 3,499)Buy Now ($ 4,499)
Find Help
Legal
Explore